Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 10th Ave
Columbus, OH 43210Phone+1 614-293-8619Fax+1 614-293-6420
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Minnesota Medical SchoolClass of 2007
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine
Certifications & Licensure
- CA State Medical License 2008 - Present
- OH State Medical License 2013 - 2021
- MO State Medical License 2011 - 2014
- NC State Medical License 2011 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Statin Use in Patients With Acute VTE Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 29 citationsThe prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTHJeffrey I. Zwicker, Tzu-Fei Wang, Daniel J. DeAngelo, Mandy N Lauw, Jean M. Connors
Journal of Thrombosis and Haemostasis. 2020-02-01 - 84 citationsFunctional analysis of human hematopoietic stem cell gene expression using zebrafish.Craig E. Eckfeldt, Eric M. Mendenhall, Catherine M. Flynn, Tzu-Fei Wang, Michael A. Pickart
Plos Biology. 2005-07-05 - 38 citationsA cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L. Sood, Dunlei Cheng, Margaret V. Ragni, Craig M. Kessler, Doris Quon
Blood Advances. 2014-12-06
Abstracts/Posters
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialTzu-Fei Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding RisksTzu-Fei Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospe...Tzu-Fei Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- A Retrospective Study of Clinical and Laboratory Characteristics in Patients Diagnosed with Platelet Storage Pool Deficiency2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: